Suggestions
Juli P. Miller, PhD
Senior Manager, Medical and Scientific Writing at Jazz Pharmaceuticals
Juli P. Miller, PhD is the Vice President of Corporate Affairs and Investor Relations at Adaptimmune, a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapy products.1 Here are some key details about her career and background:
Professional Experience
Dr. Miller has an extensive career in the pharmaceutical and biotechnology industry:
- She joined Adaptimmune in August 2016 as a Senior Director1
- She was promoted to Vice President of Investor Relations in July 20211
- In June 2022, she became Vice President of Corporate Affairs and Investor Relations1
Prior to Adaptimmune, she held positions at:
- Jazz Pharmaceuticals as an Associate Director (2014-2016)1
- Shire as a Manager (2012-2014)1
- ViroPharma Incorporated as a Senior Medical Writer (2007-2012)1
- Synchrogenix (a Certara company) as a Medical Writer (2005-2007)1
Education
Dr. Miller has a strong academic background:
- PhD in Immunology from the University of Pennsylvania (2001-2005)1
- Master's degree in Immunology from Imperial Cancer Research Fund (now Cancer Research UK) (1998-2001)1
- Bachelor's degree in Biology, Anthropology, and English from Bryn Mawr College (1990-1994)1
Research and Expertise
During her PhD, Dr. Miller conducted original research in B- and T-cell development and the impact of aging on the immune system.1 Her expertise includes regulatory and medical writing, particularly for FDA and EMA meeting packages and drug submissions.1
In her current role at Adaptimmune, Dr. Miller is responsible for investor relations and corporate affairs, serving as a key point of contact for financial communications and media relations.234
